JPMHC 2019

The J.P. Morgan Healthcare Conference has grown. How can we make it work for everyone?
Stat
Wed, 02/13/19 - 12:02 am
JPMHC 2019
Why Gilead Sciences Stock Perked Up in January
Motley Fool
Sun, 02/10/19 - 01:51 pm
Gilead Sciences
JPMHC 2019
Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Endpoints
Thu, 01/17/19 - 11:10 am
Eli Lilly
Loxo Oncology
M&A
JPMHC 2019
Attendees fed up with venue, high prices call to move JPM out of San Francisco
Fierce Biotech
Tue, 01/15/19 - 10:03 am
JPMHC 2019
Is JPM worth it? As the buzzy conference dies down, debate on its value rumbles on
Endpoints
Mon, 01/14/19 - 11:35 pm
JPMHC 2019
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
Fierce Biotech
Mon, 01/14/19 - 11:35 am
IPOs
Kaleido Biosciences
Cirius Therapeutics
NASDAQ
JPMHC 2019
government shutdown
Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs
Fierce Pharma
Sat, 01/12/19 - 11:37 am
JPMHC 2019
M&A
Pfizer
Biogen
Amarin
Want to buy Clovis? Step up. ‘Everybody knows where to find me,’ CEO says
Fierce Pharma
Fri, 01/11/19 - 08:12 pm
M&A
Patrick Mahaffy
Pharma CEOs
Clovis Oncology
JPMHC 2019
The winners and losers from JPM 2019
Biopharma Dive
Fri, 01/11/19 - 11:51 am
JPMHC 2019
Loxo Oncology
SAGE Therapeutics
Amarin
FDA
M&A
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
Fri, 01/11/19 - 10:25 am
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
JP Morgan Healthcare Conference Update: Sage, Mersana, Shutdown Woes and Babies
BioSpace
Thu, 01/10/19 - 08:48 pm
JPMHC 2019
SAGE Therapeutics
SAGE-217
Mersana
Novavax
Denali Therapeutics
AstraZeneca
Amarin
FDA
government shutdown
JPM19: Spark looks at scale, manufacturing as gene therapy matures
Biopharma Dive
Thu, 01/10/19 - 08:45 pm
JPMHC 2019
Spark Therapeutics
gene therapy
Luxturna
What Intuitive Surgical Just Said About Its Future
Motley Fool
Thu, 01/10/19 - 08:41 pm
JPMHC 2019
Intuitive Surgical
robotic surgery
devices
JPM19: A biotech's M&A invitation, Editas' next CRISPR step and more from day 3
Biopharma Dive
Thu, 01/10/19 - 12:31 pm
Editas
CRISPR
GSK
Tesaro
Clovis Oncology
M&A
AbbVie
JPMHC 2019
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Thu, 01/10/19 - 09:52 am
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
Thu, 01/10/19 - 09:50 am
JNJ
Pfizer
Eli Lilly
Jamie Dimon
Amazon
JPMHC 2019
3 Big Reasons Why AbbVie Isn't Worried About Humira
Yahoo/Motley Fool
Thu, 01/10/19 - 09:47 am
AbbVie
Humira
JPMHC 2019
For tiny biotechs, J.P. Morgan is a big opportunity — and a big cost
Stat
Thu, 01/10/19 - 09:46 am
JPMHC 2019
Glaukos Keeps Its Eye on the Prize at J.P. Morgan
Medical Devices and Diagnostics Industry
Thu, 01/10/19 - 12:19 am
JPMHC 2019
Glaukos
glaucoma
devices
Rewiring R&D: The FierceBiotech JPM 2019 breakfast debate
Fierce Biotech
Wed, 01/9/19 - 12:58 pm
JPMHC 2019
R&D
artificial intelligence
machine learning

Pages